Introduction
Physiological changes that occur during pregnancy complicate diagnosis of thyroid dysfunction, particularly in the first trimester. Hormonal changes and increased metabolic demands during pregnancy produce complex alterations in thyroid hormone concentrations. Increased concentrations of human chorionic gonadotropin stimulates thyroid hormone secretion, thereby reducing TSH concentrations in the body. Due to the complexities of hormone changes, it is recommended to screen for thyroid dysfunction before pregnancy or during the early part of the first trimester. For women who appear euthyroid but may have subtle thyroid dysfunction, pregnancy may result in subclinical or overt hypothyroidism. In addition, thyroid disease is relatively common in women of reproductive age. For these reasons, experts including the National Academy of Clinical Biochemistry have recommended trimester specific reference intervals for thyroid function tests; some of which likely need to be method specific. These reference intervals should be determined using individuals who do not have thyroid autoantibodies. Ethnic background can play a role both in the prevalence of thyroid dysfunction and in the establishment of reference intervals. The objectives of our study were to establish reference intervals for thyroid functions tests by ethnic group for the first trimester of pregnancy (weeks 10-13) in subjects who are thyroid antibody negative, and to examine the prevalence of thyroid autoantibodies by ethnic group.
Materials and Methods
•Serum specimens submitted for first trimester maternal screen testing were collected after completion of clinical testing.
•Testing was performed on the ARCHITECT i2000 SR for TSH, FT4, TT4, FT3, TT3, T-Uptake, TgAb, and TPOAb.
•Total hormone binding ratio (THBR) was calculated per the manufacturer's package insert: THBR = 1/T-Uptake.
•Free thyroxine index (FT4I) was calculated per the manufacturer's package insert: FT4I = TT4 x THBR.
•The central 95% reference intervals were determined non-parametrically for all assays.
•TSH reference interval excluded TgAb and TPOAb positive subjects.
•Reference intervals for FT4, TT4, FT4I, FT3, and TT3 were determined excluding antibody positive subjects with abnormal TSH based on the determined reference interval for this group.
•Reference intervals were also determined for non-pregnant subjects in the same manner as detailed above where antibody negative subjects were used to determine the TSH reference interval and the reference intervals for all other analytes were determined using antibody negative subjects with normal TSH results.
•Reference intervals were evaluated for all subjects combined by week of gestation and for all weeks of gestation combined by ethnic group.
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